352 related articles for article (PubMed ID: 9372686)
21. beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells.
Hallsworth MP; Twort CH; Lee TH; Hirst SJ
Br J Pharmacol; 2001 Feb; 132(3):729-41. PubMed ID: 11159726
[TBL] [Abstract][Full Text] [Related]
22. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis of hemopoietic cells by the human granulocyte-macrophage colony-stimulating factor mutant E21R.
Iversen PO; To LB; Lopez AF
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2785-9. PubMed ID: 8610118
[TBL] [Abstract][Full Text] [Related]
24. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival.
Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C
Clin Exp Allergy; 2006 Jan; 36(1):52-8. PubMed ID: 16393266
[TBL] [Abstract][Full Text] [Related]
25. Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro.
Sato E; Nelson DK; Koyama S; Hoyt JC; Robbins RA
Antimicrob Agents Chemother; 2001 Feb; 45(2):401-6. PubMed ID: 11158732
[TBL] [Abstract][Full Text] [Related]
26. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.
Rot A; Krieger M; Brunner T; Bischoff SC; Schall TJ; Dahinden CA
J Exp Med; 1992 Dec; 176(6):1489-95. PubMed ID: 1281207
[TBL] [Abstract][Full Text] [Related]
27. Minute quantities of granulocyte-macrophage colony-stimulating factor prolong eosinophil survival.
Esnault S; Malter JS
J Interferon Cytokine Res; 2001 Feb; 21(2):117-24. PubMed ID: 11244576
[TBL] [Abstract][Full Text] [Related]
28. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines.
Ebisawa M; Liu MC; Yamada T; Kato M; Lichtenstein LM; Bochner BS; Schleimer RP
J Immunol; 1994 May; 152(9):4590-6. PubMed ID: 8157972
[TBL] [Abstract][Full Text] [Related]
29. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.
Létuvé S; Lajoie-Kadoch S; Audusseau S; Rothenberg ME; Fiset PO; Ludwig MS; Hamid Q
J Allergy Clin Immunol; 2006 Mar; 117(3):590-6. PubMed ID: 16522458
[TBL] [Abstract][Full Text] [Related]
30. Eosinophil activation by eotaxin--eotaxin primes the production of reactive oxygen species from eosinophils.
Honda K; Chihara J
Allergy; 1999 Dec; 54(12):1262-9. PubMed ID: 10688429
[TBL] [Abstract][Full Text] [Related]
31. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction.
Ohnishi T; Kita H; Weiler D; Sur S; Sedgwick JB; Calhoun WJ; Busse WW; Abrams JS; Gleich GJ
Am Rev Respir Dis; 1993 Apr; 147(4):901-7. PubMed ID: 8466126
[TBL] [Abstract][Full Text] [Related]
32. Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts.
Noso N; Sticherling M; Bartels J; Mallet AI; Christophers E; Schröder JM
J Immunol; 1996 Mar; 156(5):1946-53. PubMed ID: 8596049
[TBL] [Abstract][Full Text] [Related]
33. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.
Levi-Schaffer F; Temkin V; Malamud V; Feld S; Zilberman Y
J Immunol; 1998 Jun; 160(11):5554-62. PubMed ID: 9605160
[TBL] [Abstract][Full Text] [Related]
34. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.
Tai PC; Spry CJ
Clin Exp Immunol; 1990 Jun; 80(3):426-34. PubMed ID: 2197048
[TBL] [Abstract][Full Text] [Related]
35. Protease-dependent activation of nasal polyp epithelial cells by airborne fungi leads to migration of eosinophils and neutrophils.
Shin SH; Lee YH; Jeon CH
Acta Otolaryngol; 2006 Dec; 126(12):1286-94. PubMed ID: 17101590
[TBL] [Abstract][Full Text] [Related]
36. Differentiation stages of eosinophils characterized by hyaluronic acid binding via CD44 and responsiveness to stimuli.
Watanabe Y; Hashizume M; Kataoka S; Hamaguchi E; Morimoto N; Tsuru S; Katoh S; Miyake K; Matsushima K; Tominaga M; Kurashige T; Fujimoto S; Kincade PW; Tominaga A
DNA Cell Biol; 2001 Apr; 20(4):189-202. PubMed ID: 11403716
[TBL] [Abstract][Full Text] [Related]
37. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
38. Possible involvement of C-C chemokines in functional augmentation of adhesion molecules in asthmatic patients.
Saito N; Yamada Y; Sannohe S; Honda K; Adachi T; Kayaba H; Chihara J
Lung; 2002; 180(5):251-63. PubMed ID: 12489019
[TBL] [Abstract][Full Text] [Related]
39. Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells.
Burke-Gaffney A; Hellewell PG
Biochem Biophys Res Commun; 1996 Oct; 227(1):35-40. PubMed ID: 8858099
[TBL] [Abstract][Full Text] [Related]
40. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
El-Shazly A; Ishikawa T
Mediators Inflamm; 1999; 8(3):177-9. PubMed ID: 10704057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
